Rapid and high-yield solution-phase synthesis of DOTA-Tyr3-octreotide and DOTA-Tyr3-octreotate using unprotected DOTA

This publication has 14 references indexed in Scilit:

• Modification of the Structure of a Metallopeptide: Synthesis and Biological Evaluation of ¹¹¹In-Labeled DOTA-Conjugated Rhenium-Cyclized α-MSH Analogues
  Journal of Medicinal Chemistry, 2002
• Pm-149 DOTA bombesin analogs for potential radiotherapy
  Nuclear Medicine and Biology, 2002
• [177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients
  European Journal of Nuclear Medicine and Molecular Imaging, 2001
• [177Lu-DOTA0,Tyr3]octreotate for somatostatin receptor-targeted radionuclide therapy
  International Journal of Cancer, 2001
• OctreoTherTM: Ongoing Early Clinical Development of a Somatostatin-Receptor-Targeted Radionuclide Antineoplastic Therapy
  Digestion, 2000
• Yttrium-90 DOTATOC: first clinical results
  European Journal of Nuclear Medicine and Molecular Imaging, 1999
• Direct solid-phase synthesis of octreotide conjugates
  Bioorganic & Medicinal Chemistry, 1999
• Radiometal-Labelled Macrocyclic Chelator-Derivatised Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy
  Chemistry – A European Journal, 1999
• Total Solid-Phase Synthesis of 1,4,7,10-Tetraazacyclododecane-N,N‘,N‘‘,N‘‘‘-tetraacetic Acid-Functionalized Peptides for Radioimmunotherapy
  Bioconjugate Chemistry, 1999
• Direct synthesis of [DOTA-DPhe1]-octreotide and [DOTA-DPhe1, Tyr3]-octreotide (SMT487): Two conjugates for systemic delivery of radiotherapeutical nuclides to somatostatin receptor positive tumors in man
  Bioorganic & Medicinal Chemistry Letters, 1998